Description

The fund primarily targets companies positioned to gain from scientific and technological breakthroughs, typically dedicating a minimum of 80% of its portfolio to their equity holdings. Additionally, it possesses the flexibility to allocate up to half of its investments to non-domestic securities, which can encompass those from developing nations.